Robert Hershberg - Feb 1, 2023 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
President and CEO, Director
Signature
/s/ Paul Bavier, Attorney-in-Fact for Robert Hershberg
Stock symbol
HLVX
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 03:17 PM
Previous filing
Jun 16, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLVX Common Stock Award $0 +188K +24.18% $0.00 965K Feb 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLVX Stock Option (Right to Buy) Award $0 +382K $0.00 382K Feb 1, 2023 Common Stock 382K $18.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 1, 2023, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
F2 The option is exercisable as it vests. The option will vest with respect to 25% of the shares of common stock on February 1, 2024 and will vest with respect to the remaining shares in equal monthly installments over the following three years subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.